forecast
CAR T-Cell Therapy Could Extend Beyond Blood Cancers
CAR T-cell therapy has been very successful against leukemias, lymphomas, and myelomas, and Marrazzo expects it to be applied in the next 5 to 10 years to solid tumors that make up the other 93 percent of cancer, including lung, breast, and colon cancer.
forecastpending
Speaker
JeffEvidence Quote
“I think over the course of the next 5 to 10 years or even sooner, we're going to see the first progress in applying this T-cell engineering approach”
Created: 11/11/2026, 6:53:25 PM
Your notes
Loading notes...